Amdocs (NASDAQ:DOX) Releases Q2 2025 Earnings Guidance

Amdocs (NASDAQ:DOX) issued an update on its second quarter 2025 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 1.670-1.730 for the period, compared to the consensus estimate of 1.710. The company issued revenue guidance of $1.1 billion-$1.1 billion, compared to the consensus revenue estimate of $1.1 billion. Amdocs also updated its FY 2025 guidance to 6.859-7.116 EPS.

Amdocs Stock Performance

NASDAQ DOX traded down $2.42 during trading hours on Thursday, reaching $85.72. The company’s stock had a trading volume of 709,934 shares, compared to its average volume of 621,482. The stock has a market cap of $9.68 billion, a PE ratio of 20.23, a PEG ratio of 1.47 and a beta of 0.71. The business has a 50-day simple moving average of $85.96 and a 200 day simple moving average of $86.40. Amdocs has a 52 week low of $74.41 and a 52 week high of $94.04. The company has a current ratio of 1.20, a quick ratio of 1.20 and a debt-to-equity ratio of 0.21.

Amdocs (NASDAQ:DOX) last released its quarterly earnings data on Tuesday, February 4th. The technology company reported $1.45 earnings per share for the quarter, missing analysts’ consensus estimates of $1.64 by ($0.19). Amdocs had a return on equity of 18.69% and a net margin of 9.85%. Equities research analysts predict that Amdocs will post 6.19 earnings per share for the current fiscal year.

Amdocs Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Sunday, April 20th. Investors of record on Monday, March 31st will be issued a dividend of $0.527 per share. This is a boost from Amdocs’s previous quarterly dividend of $0.48. The ex-dividend date is Monday, March 31st. This represents a $2.11 annualized dividend and a yield of 2.46%. Amdocs’s payout ratio is presently 45.28%.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the stock. Oppenheimer raised their price objective on shares of Amdocs from $98.00 to $105.00 and gave the company an “outperform” rating in a research report on Wednesday, November 13th. StockNews.com upgraded shares of Amdocs from a “buy” rating to a “strong-buy” rating in a research report on Wednesday. Finally, Barclays cut their price objective on Amdocs from $113.00 to $111.00 and set an “overweight” rating for the company in a research report on Thursday, November 14th. One equities research analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of $101.20.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.